We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4980:TSEDexerials Corp. Analysis

Data as of 2026-07-26 - not real-time

¥3,551.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Dexerials is trading at ¥3,551, which sits below its 20‑day (¥3,978) and 50‑day (¥4,168) moving averages, indicating short‑term weakness, while remaining above the 200‑day SMA of ¥2,970, suggesting the longer trend is still intact. The RSI of 37 points to modest oversold pressure, but the MACD histogram is negative and the MACD line trails the signal, delivering a bearish technical signal. On the fundamentals side, revenue grew 14% year‑over‑year and margins are robust – gross margin 56%, operating margin 33% and net profit margin 25% – delivering a ROE of 27% and ROA of 15%, well above many peers. The stock’s forward P/E of 23 is notably lower than the industry average of 33, positioning it as relatively cheap on earnings, though the price‑to‑book of 5.4 and a debt‑to‑equity of 15.1 signal a leveraged balance sheet. Dividend yield sits at 1.8% with a payout ratio of 36%, comfortably supported by operating cash flow of ¥27.5 bn and free cash flow of ¥6.8 bn. High 30‑day volatility (≈68%) and a beta near 1.1 add price swing risk, while decreasing volume and a neutral trend direction temper short‑term upside expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 20‑day and 50‑day SMAs
  • Bearish MACD signal
  • Proximity to support at ¥3,402

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 14% revenue growth with strong margins
  • P/E well below industry average
  • Sustainable dividend with 36% payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • High ROE (27%) and consistent cash generation
  • Diversified product exposure across electronics, optics, and automotive
  • Undervalued relative to peers despite leveraged balance sheet

Key Metrics & Analysis

Financial Health

Revenue Growth14.20%
Profit Margin24.61%
P/E Ratio22.2
ROE27.29%
ROA15.42%
Debt/Equity15.09
P/B Ratio5.4
Op. Cash Flow¥27.5B
Free Cash Flow¥6.8B
Industry P/E32.9

Technical Analysis

TrendNeutral
RSI37.2
Support¥3,402.00
Resistance¥4,866.00
MA 20¥3,978.10
MA 50¥4,168.20
MA 200¥2,970.38
MACDBearish
VolumeDecreasing
Fear & Greed Index88.25

Valuation

Fair Value¥942.15
Target Price¥4,560.00
Upside/Downside28.41%
GradeFair
TypeBlend
Dividend Yield1.80%

Risk Assessment

Beta1.11
Volatility68.00%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.